Tower Research Capital LLC (Trc) Immuno Precise Antibodies Ltd. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
Shares
12 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$530,8520.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$26,5880.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$14,0080.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$13,9760.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$12,0040.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $8.44M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...